UPPTHERA
PrivateLast Round
Series B
Extension
Jul 24, 2023
Total Funding Raised
$41.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
UPPTHERA is a pharmaceutical company that develops innovative drugs based on targeted protein degradation technology to address unmet medical needs in oncology and other disease areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UPPTHERA Comparables
Compare UPPTHERA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 88% | |
| Ubix Therapeutics | 88% | |
| Plexium | 86% | |
UPPTHERA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 24, 2023 | ||||
| Series B | May 18, 2022 | ||||
| Series A | Jul 14, 2020 | ||||
| Pre Seed | Mar 1, 2019 |
Key People
Founding team and executive leadership
UPPTHERA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series B, Series A |
| Paratus Investment | Series B |
| Meritz Securities Co., Ltd. | Series B |
| SBI Investment Korea | Series B |
| Enlight Ventures | Series B, Series A |
| IMM Investment | Series B, Series A |
| SBI Investment Co., Ltd. | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 74% MoM.
- May 1, 2025
Monthly visitors increased 1253% MoM, reaching 2.3K.
UPPTHERA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about UPPTHERA's valuation, stock price, and market status.